Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite®) solution in the treatment of ocular infections
Canan Asli UtineYeditepe University, Department of Ophthalmology, Istanbul, Turkey and Ocular Surface Disease and Dry Eye Clinic, Cornea and External Disease Service, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USAAbstract: Azithromycin is an azalide tha...
Saved in:
Main Author: | Utine CA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/a993340aa4c94f4084a85d2aeaaa5a9c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Azithromycin in DuraSite® for the treatment of blepharitis
by: Jodi Luchs
Published: (2010) -
Intracorneal ring implantation using Intralase® with partial coverage of the cone in a patient after an alkaline injury
by: Cakir H, et al.
Published: (2011) -
Topical azithromycin or ofloxacin for endophthalmitis
by: Stewart ML, et al.
Published: (2012) -
PERSIST: Physician's Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
by: Mah F, et al.
Published: (2012) -
Fluoroquinolones compared to 1% azithromycin in DuraSite® for bacterial conjunctivitis [from Lichenstein and Granet] and Response to correspondence [from Friedlaender and Protzko] ||FREE PAPER||
by: Steven J Lichtenstein, et al.
Published: (2008)